Advances in Engineering Cells for Cancer Immunotherapy

Cancer immunotherapy aims to utilize the host immune system to kill cancer cells. Recent representative immunotherapies include T-cell transfer therapies, such as chimeric antigen receptor T cell therapy, antibody-based immunomodulator therapies, such as immune checkpoint blockade therapy, and cytok...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao, Li, Teng, Shen, Shiyang, Wang, Jinqiang, Abdou, Peter, Gu, Zhen, Mo, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831467/
https://www.ncbi.nlm.nih.gov/pubmed/31695806
http://dx.doi.org/10.7150/thno.38583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831467/
https://www.ncbi.nlm.nih.gov/pubmed/31695806
http://dx.doi.org/10.7150/thno.38583

Ejemplares similares